Please assess the completion status of the following clinical trial:

Trial Title: Duloxetine Versus Placebo for Osteoarthritis Knee Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female outpatients with osteoarthritis knee pain.~Exclusion Criteria:~* Cardiovascular, hepatic, renal, respiratory, or hematologic illness, or other medical or psychiatric condition that, in the opinion of the investigator, would compromise participation or be likely to lead to hospitalization during the course of the study.~* Acute liver injury (such as hepatitis) or severe cirrhosis.~* Previous exposure to duloxetine.~* Body Mass Index (BMI) over 40.~* Major depressive disorder.~* Daily use of narcotics.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: EXPERIMENTAL): duloxetine 30 mg, daily (QD), by mouth (PO) for 1 week then duloxetine 60 mg QD, PO for 6 weeks then duloxetine 60 mg or 120 mg QD, PO for 6 weeks
- B (Type: PLACEBO_COMPARATOR): placebo daily (QD), by mouth (PO) for 13 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).